Bringing life-changing treatments faster: Introducing an innovative clinical trial management solution

We’ve created an innovative clinical trial acceleration platform that helps pharmaceutical companies bring life-changing treatments to patients faster.

Built on deep domain expertise and advanced technical capabilities, it streamlines a critical segment of the trial process such as removing bottlenecks, optimising workflows, and providing the visibility needed to make smarter decisions. Because when clinical trials run faster and smoother, everyone benefits, especially the people waiting for new therapies.

Addressing the complexity and challenges of clinical trial management

Managing clinical trials is a complex, resource-intensive process. Trials span multiple years, cost billions, and involve institutions across continents, including clinical centres, hospitals, and research organisations.

Patient recruitment stands out as one of the biggest obstacles. The impact is costly: 85% of clinical trials face delays, and 94% are pushed back by more than a month. Every day lost can mean potential revenue losses ranging from $600K to $8 million, while nearly half of all delays stem from slow patient recruitment and retention.

In addition, the complexities of clinical trials make it difficult for pharmaceutical companies to stay on schedule, track progress, access real-time data, and apply advanced analytics to optimise decision-making. The result? Delays that keep patients waiting for life-changing treatments.

Overcoming these challenges is critical to ensuring treatments reach patients without costly setbacks. That is why we created a scalable, future-ready solution that could streamline trial management, improve efficiency, and reduce operational costs.

Introducing Axceler8 Rx – a breakthrough in clinical trial management

We joined forces with Arthur D. Little, the world’s first management consulting firm, with expertise in innovation, technology, and strategy, and created Axceler8 Rx. The product is a modern, single-tenant platform designed specifically for pharmaceutical companies. Its main goal is to enhance efficiency, streamline operations, and support large-scale trial management.

The platform is built around two key capabilities: clinical trial modelling and monitoring.

Clinical trial modelling

This is a forecasting process that happens before a clinical trial starts. The idea is to use as much relevant information as possible to predict how the trial will unfold.

In this case, the platform pulls in diverse industry data sources such as historical trial results, patient demographics, disease prevalence, regulatory timelines, and operational metrics. It then applies domain expertise to process this data.

By combining these, the platform can predict:

• Trial progression – how the trial is likely to advance step-by-step, including milestones and possible bottlenecks.
• Outcomes – likely success rates, potential issues, or risks to address in advance.
• Timelines – realistic estimates of how long the trial will take from recruitment to completion.

This modelling helps pharmaceutical companies plan better, allocate resources efficiently, and avoid costly delays before the trial even starts.

Clinical trial monitoring

Monitoring includes keeping a close, ongoing watch on how a clinical trial is progressing once it’s underway. In this case, the platform continuously tracks key trial metrics, for example, patient recruitment numbers, site performance, data collection status, and compliance milestones. This ensures that trial managers always have real-time visibility into what’s happening.

All of this information is presented in a centralised dashboard, which gives an at-a-glance overview of the most important data. That way, managers can quickly spot potential problems, make informed decisions, and take corrective actions early.

From predictive insights on enrollment to advanced dashboards and reporting, Axceler8 Rx delivers tangible benefits, including streamlined site activation, optimised participant recruitment, and improved target management.

By boosting efficiency and shortening time-to-market, it helps pharmaceutical companies bring new treatments to patients faster, advancing medical research.

The future of clinical trials starts now

Axceler8 Rx has already caught the eye of pharma industry leaders. One of the first adopters is a global, Fortune 500, biopharmaceutical company.

The next step? We now focus on integrating the platform with existing clinical trial management systems to further streamline operations and improve data accessibility.

And we’re just getting started. The future of clinical trial management is here, and we’re leading the way.